Perfluorooctyl bromide (Perflubron) stimulates mucin secretion in the ferret trachea

Chest

Volumn 115, Issue 3, 1999, Pages 823-828

  Kishioka, Chikako ^a   Dorighi, Matthew P ^a   Rubin, Bruce K ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Arachidonic acid; Lysozyme; Mucin; Mucociliary clearance; Partial liquid ventilation; Secretagogue

Indexed keywords

ARACHIDONIC ACID; LYSOZYME; NORDIHYDROGUAIARETIC ACID; PERFLUOROOCTYL BROMIDE;

ANIMAL TISSUE; ARTICLE; ENZYME RELEASE; FERRET; MUCOCILIARY CLEARANCE; MUCOCILIARY TRANSPORT; MUCUS SECRETION; NONHUMAN; PRIORITY JOURNAL; TRACHEA;

EID: 0033035033     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.115.3.823     Document Type: Article

References (29)

1. 1 Long DM, Liu PS, Szanto PS, et al. Initial observations with a new X-ray contrast agent: radiopaque fluorocarbon. Rev Surg 1972; 29:71-6
2. 2 Leach CL, Holm B, Morin III FC, et al. Partial liquid ventilation in premature lambs with respiratory distress syndrome: efficacy and compatibility with exogenous surfactant. J Pediatr 1995; 126:412-20
3. 3 Overbeck MC, Pranikoff T, Yadao CM, et al. Efficacy of perfluorocarbon partial liquid ventilation in a large animal model of acute respiratory failure. Crit Care Med 1996; 24:1208-1214
4. 4 Leach CL, Greenspan JS, Rubenstein SD, et al. Partial liquid ventilation with perflubron in premature infants with severe respiratory distress syndrome. N Engl J Med 1996; 335: 761-67
5. 5 Rubin BK, Ramirez O, King M. Mucus-depleted frog palate as a model for the study of mucociliary clearance. J Appl Physiol 1990; 69:424-29
6. 6 Kishioka C, Cheng P-W, Seftor REB, et al. Regulation of mucin secretion in the ferret trachea. Otolaryngol Head Neck Surg 1997; 177:480-86
7. 7 Shimura S, Sasaki T, Ikeda K, et al. VIP augments cholinergic-induced glycoconjugate secretion in tracheal submucosal glands. J Appl Physiol 1988; 65:2537-2544
8. 8 Fung DC, Beacock DJ, Richardson PS. Vagal control of mucus glycoconjugate secretion into the feline trachea. J Physiol 1992; 453:435-447
9. 9 Kuo HP, Rohde JA, Barnes PJ, et al. Cigarette smoke-induced airway goblet cell secretion: dose-dependent differential nerve activation. Am J Physiol 1992; 263:L161-L167
10. 10 Hybbinette JC, Mercke U. Effects of sympathomimetic agonists and antagonists on mucociliary activity. Acta Oto Laryngol 1982; 94:121-130
11. 11 Goswami SK, Ohashi M, Stathas P, et al. Platelet-activating factor stimulates secretion of respiratory glycoconjugate from human airways in culture. J Allergy Clin Immunol 1989; 84:726-734
12. 12 Lundgren JD, Shelhamer JH, Kaliner MA. The role of eicosanoids in respiratory mucus hypersecretion. Ann Allergy 1985; 55:5-8
13. 13 Hirata F, Schiffmann E, Venkatasubramanian K, et al. A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids. Proc Natl Acad Sci USA 1980; 77:2533-2536
14. 14 Blackwell GJ, Carnuccio R, DiRosa M, et al. Macrocortin: a polypeptide causing the antiphospholipase effect of glucocorticoids. Nature 1980; 287:147-49
15. 15 Adler KB, Holden SW, Repine JE. Oxygen metabolites stimulate release of high-molecular-weight glycoconjugates by cell and organ cultures of rodent respiratory epithelium via an arachidonic acid-dependent mechanism. J Clin Invest 1990; 85:75-85
16. 16 Lundgren JD, Kaliner M, Logun C, et al. Platelet activating factor and tracheobronchial respiratory glycoconjugate release in feline and human explants: involvement of the lipoxygenase pathway. Agents Actions 1990; 30:329-337
17. 17 Marom Z, Shelhamer JH, Kaliner M. Effects of arachidonic acid, monohydroxyeicosatetraenoic acid, and prostaglandins on the release of mucous glycoproteins from human airways in vitro. J Clin Invest 1981; 67:1695-1702
18. 18 Leigh MW, Cheng PW, Boat TF. Developmental changes of ferret tracheal mucin composition and biosynthesis. Biochemistry 1989; 28:9440-9446
19. 19 Tom-Moy M, Basbaum CB, Nadel JA. Localization and release of lysozyme from ferret trachea: effects of adrenergic and cholinergic drugs. Cell Tissue Res 1983; 228:549-562
20. 20 Rubin BK, Ramirez O, King M. Mucus rheology and transport in neonatal respiratory distress syndrome and the effect of surfactant therapy. Chest 1992; 101:1080-1085
21. 21 De Sanctis GT, Tomkiewicz RP, Rubin BK, et al. Exogenous surfactant enhances mucociliary clearance in the anaesthetized dog. Eur Respir J 1994; 7:1616-1621
22. 22 Togias AG, Naclerio RM, Peters SP, et al. Local generation of sulfidopeptide leukotrienes upon nasal provocation with cold, dry air. Am Rev Respir Dis 1986; 133:1133-1137
23. 23 Kaminsky DA, Jones K, Schoene RB, et al. Urinary leukotriene E4 levels in high altitude pulmonary edema. A possible role for inflammation. Chest 1996; 110:939-945
24. 24 Finnerty JP, Wood-Baker R, Thomson H, et al. Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist. Am Rev Respir Dis 1992; 145:746-49
25. 25 Goetter WE. The pathophysiology of asthma. Extrinsic influences other than immunologic. Clin Chest Med 1984; 5:589-598
26. 26 Lacy ER, Cowart KS, Hund III P. Effects of chronic superficial injury on the rat gastric mucosa. Gastroenterology 1992; 103:1179-1191
27. 27 Hejal R, Strohl KP, Erokwu B, et al. Pathways and mechanisms involved in neural control of laryngeal submucosal gland secretion. J Appl Physiol 1993; 75:2347-2352
28. 28 Sharma JN. The role of the kallikrein-kinin system in joint inflammatory disease. Pharmacol Res 1991; 23:105-112
29. 29 Holtzman MJ. Arachidonic acid metabolism in airway epithelial cells. Annu Rev Physiol 1992; 54:303-329